These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 10651115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
    Lucas JJ, Hernández F, Gómez-Ramos P, Morán MA, Hen R, Avila J.
    EMBO J; 2001 Jan 15; 20(1-2):27-39. PubMed ID: 11226152
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia.
    Beasley C, Cotter D, Khan N, Pollard C, Sheppard P, Varndell I, Lovestone S, Anderton B, Everall I.
    Neurosci Lett; 2001 Apr 20; 302(2-3):117-20. PubMed ID: 11290401
    [Abstract] [Full Text] [Related]

  • 6. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta.
    Liu F, Schaphorst KL, Verin AD, Jacobs K, Birukova A, Day RM, Bogatcheva N, Bottaro DP, Garcia JG.
    FASEB J; 2002 Jul 20; 16(9):950-62. PubMed ID: 12087056
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.
    Chen G, Huang LD, Jiang YM, Manji HK.
    J Neurochem; 1999 Mar 20; 72(3):1327-30. PubMed ID: 10037507
    [Abstract] [Full Text] [Related]

  • 10. An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder.
    Beasley C, Cotter D, Everall I.
    Schizophr Res; 2002 Nov 01; 58(1):63-7. PubMed ID: 12363391
    [Abstract] [Full Text] [Related]

  • 11. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A.
    Oncogene; 2000 Jan 27; 19(4):537-45. PubMed ID: 10698523
    [Abstract] [Full Text] [Related]

  • 12. The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activity.
    Leroy K, Menu R, Conreur JL, Dayanandan R, Lovestone S, Anderton BH, Brion JP.
    FEBS Lett; 2000 Jan 07; 465(1):34-8. PubMed ID: 10620702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients.
    Kozlovsky N, Belmaker RH, Agam G.
    Am J Psychiatry; 2000 May 07; 157(5):831-3. PubMed ID: 10784483
    [Abstract] [Full Text] [Related]

  • 15. Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
    Zurawel RH, Chiappa SA, Allen C, Raffel C.
    Cancer Res; 1998 Mar 01; 58(5):896-9. PubMed ID: 9500446
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila.
    Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH.
    Neuron; 2002 May 16; 34(4):509-19. PubMed ID: 12062036
    [Abstract] [Full Text] [Related]

  • 18. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T, Vidal-Puig A.
    Biochem Biophys Res Commun; 2002 Jun 07; 294(2):324-8. PubMed ID: 12051714
    [Abstract] [Full Text] [Related]

  • 19. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.
    Acta Neuropathol; 2002 Feb 07; 103(2):91-9. PubMed ID: 11810173
    [Abstract] [Full Text] [Related]

  • 20. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P, Madi L, Bar-Yehuda S, Barer F, Del Valle L, Khalili K.
    Oncogene; 2002 Jun 06; 21(25):4060-4. PubMed ID: 12037688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.